1. Home
  2. REBN vs AEON Comparison

REBN vs AEON Comparison

Compare REBN & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reborn Coffee Inc.

REBN

Reborn Coffee Inc.

N/A

Current Price

$1.39

Market Cap

11.5M

ML Signal

N/A

Logo AEON Biopharma Inc.

AEON

AEON Biopharma Inc.

N/A

Current Price

$0.27

Market Cap

13.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
REBN
AEON
Founded
2015
N/A
Country
United States
United States
Employees
N/A
8
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
13.0M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
REBN
AEON
Price
$1.39
$0.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $7.20
AVG Volume (30 Days)
145.2K
★ 7.4M
Earning Date
04-22-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $8,094,628.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 36.54
N/A
52 Week Low
$0.67
$0.18
52 Week High
$2.95
$1.45

Technical Indicators

Market Signals
Indicator
REBN
AEON
Relative Strength Index (RSI) 64.16 49.03
Support Level $1.37 $0.24
Resistance Level $2.02 $0.33
Average True Range (ATR) 0.13 0.03
MACD 0.07 0.00
Stochastic Oscillator 91.14 23.64

Price Performance

Historical Comparison
REBN
AEON

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is a company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in two reportable segments: Reborn Coffee, which includes both the wholesale and retail sales of coffee, water, and other beverages, and Reborn Logistics, which provides freight forwarding services.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Share on Social Networks: